TABLE 2.
Primers used in this study
Restriction sites are underlined.
Number | Name | Sequence |
---|---|---|
MK1634 | LOR_61_NcoI_F | GAGAGTCCATGGATATGAAATGTCTAAAAACATTGTTAGT |
MK1635 | LOR_61_BamHI_R | GAGAGGGATCCATTAGAACTACAGCGTGAATAAGTAC |
MK1644 | LOR_107_NcoI_F | GAGAGTCCATGGTCATGAAAATAAATCTAAGCATGCG |
MK1645 | LOR_107_XhoI_R | AGATCTCTCGAGCTCAGTAACACCCAAGTCG |
MK1791 | PSLV_3875_NcoI_F | AGAGAGCCATGGATATGAAATTAAATCTAAAAGCGAGTG |
MK1792 | PSLV_3875_XhoI_R | GAGAGTCTCGAGCCTAGAAACACCCAAATCAATAAC |
MK1793 | PSLV_3925_NcoI_F | AGAGAGCCATGGATATGAACGGTTTAAAAATGTTG |
MK1794 | PSLV_3925_XhoI_R | GAGAGTCTCGAGATTAGAGGTGCAGCGC |
MK1156 | PLR_UL_NcoI_F | GAGAGTCCATGGTGTTTTTTAAAGATTTATTCATCTTT |
MK1157 | PLR_UL_NotI_R | AGAGAGGCGGCCGCATTTACAATGAGCTTGGTTTGATA |
MK1577 | PLR_48_EcoRI_F | GAGAGTGAATTCAATGAGAAAATTAAAATATAATACTACTAGAG |
MK1578 | PLR_48_NotI_R | AGAGAGGCGGCCGCTTTACCTCATCTTTTGTATAGCTAG |
MK1684 | LOR_107d_NcoI_F | GAGAGTCCATGGCAAATGATAGCGTGTCG |